Synonym
Mideplanin; Mdl 62873; Mdl-62873; Mdl62873;
IUPAC/Chemical Name
A name could not be generated for this structure.
InChi Key
KVZUWEFUEGGULL-UHFFFAOYSA-N
InChi Code
InChI=1S/C93H109Cl2N11O32/c1-38(2)11-8-6-7-9-12-65(115)100-73-79(120)76(117)63(36-108)135-92(73)138-83-60-30-45-31-61(83)132-57-20-16-43(28-52(57)95)82(137-91-72(98-39(3)110)78(119)75(116)62(35-107)134-91)74-90(129)104-71(86(125)97-21-10-22-106(4)5)50-33-47(112)34-59(133-93-81(122)80(121)77(118)64(37-109)136-93)66(50)49-27-42(15-17-54(49)113)68(87(126)105-74)102-89(128)70(45)103-88(127)69-44-25-46(111)32-48(26-44)130-58-29-41(14-18-55(58)114)67(96)85(124)99-53(84(123)101-69)24-40-13-19-56(131-60)51(94)23-40/h13-20,23,25-34,38,53,62-64,67-82,91-93,107-109,111-114,116-122H,6-12,21-22,24,35-37,96H2,1-5H3,(H,97,125)(H,98,110)(H,99,124)(H,100,115)(H,101,123)(H,102,128)(H,103,127)(H,104,129)(H,105,126)
SMILES Code
CC(CCCCCCC(NC1C(O)C(O)C(CO)OC1Oc2c(Oc3c(Cl)cc(C(OC4C(NC(C)=O)C(O)C(O)C(CO)O4)C5C(NC(C(NCCCN(C)C)=O)c6c(c7c(O)ccc(C(NC(C8NC(C9c%10cc(Oc%11c(O)ccc(C(N)C(NC(C(N9)=O)C%12)=O)c%11)cc(O)c%10)=O)=O)C(N5)=O)c7)c(OC%13C(O)C(O)C(O)C(CO)O%13)cc(O)c6)=O)cc3)cc8cc2Oc%14c(Cl)cc%12cc%14)=O)C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
1,963.84
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Venditti M, Tarasi A, Gelfusa V, Nicastri E, Penni A, Martino P. Antimicrobial susceptibilities of enterococci isolated from hospitalized patients. Antimicrob Agents Chemother. 1993 May;37(5):1190-2. PubMed PMID: 8517714; PubMed Central PMCID: PMC187931.
2: Treviño J, Bayón C, Ardá A, Marinelli F, Gandolfi R, Molinari F, Jimenez-Barbero J, Hernáiz MJ. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy. Chemistry. 2014 Jun 10;20(24):7363-72. doi: 10.1002/chem.201303310. Epub 2014 May 7. PubMed PMID: 24805824.
3: Gandolfi R, Jovetic S, Marinelli F, Molinari F. Biotransformations of lipoglycopeptides to obtain novel antibiotics. J Antibiot (Tokyo). 2007 Apr;60(4):265-71. PubMed PMID: 17456978.
4: Goldstein BP, Candiani G, Arain TM, Romanò G, Ciciliato I, Berti M, Abbondi M, Scotti R, Mainini M, Ripamonti F, et al. Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic. Antimicrob Agents Chemother. 1995 Jul;39(7):1580-8. PubMed PMID: 7492108; PubMed Central PMCID: PMC162785.
5: Matera G, Berlinghieri MC, Barreca G, Focà A. In vitro effects of novel glycopeptide antibiotics on the reactivity of the lipopolysaccharide (LPS) of S. minnesota R595. New Microbiol. 1995 Jul;18(3):325-9. PubMed PMID: 7553371.
